Baseline characteristics
| Saxagliptin group N=33 | Basal-bolus insulin group N=33 | p Value | |
|---|---|---|---|
| Age, years | 69±10 | 67±10 | 0.16 |
| Gender, N (%) | 0.32 | ||
| Male | 13 (40) | 17 (52) | |
| Female | 20 (60) | 16 (48) | |
| Race, N (%) | 0.23 | ||
| White | 26 (79) | 30 (91) | |
| Other | 7 (21) | 3 (9) | |
| Admitting service, N (%) | 0.16 | ||
| Medicine | 6 (18) | 11 (33) | |
| Surgery | 27 (82) | 22 (67) | |
| Duration of diabetes, years | 7.5±8.5 | 7.5±5.8 | 0.64 |
| Mean A1c, % | 6.6±0.5 | 6.5±0.5 | 0.69 |
| Preadmission diabetes medications, N (%) | 0.06 | ||
| None | 8 (24) | 5 (15) | |
| Metformin | 22 (67) | 18 (55) | |
| SU | 2 (6) | 10 (30) | |
| Other | 1 (3) | 0 | |
| Weight, kg | 97.7±32.9 | 92.4±21.2 | 0.54 |
| BMI | 34.5±12.2 | 32.6±6.5 | 0.91 |
| Admission blood glucose, mg/dL | 156.1±78.9 | 152.8±52.5 | 0.52 |
| Prerandomization blood glucose, mg/dL | 154.6±37.3 | 154.8±54.6 | 0.97 |
| Serum creatinine | 1.02±0.34 | 1.10±0.35 | 0.26 |
| Presence of infection, N (%) | 4 (12) | 8 (24) | 0.20 |
BMI, body mass index.